AHA: Heart Failure, Pneumonia Payment Measures Unfair to Hospitals

The American Hospital Association told CMS that the heart failure and pneumonia 30-day episode-of-care payment measures currently under development would not accurately assess hospitals’ performance on cost, according to an AHA News Now report.

Advertisement

CMS sought feedback on heart failure and pneumonia 30-day episode-of-care payment measures being developed by the Yale-New Haven Health Systems Corp. and Center for Outcomes Research and Evaluation. The measures would calculate risk-adjusted total payments for Medicare heart failure or pneumonia patient from hospital admission through 30 days post-discharge.

In a letter to CMS, AHA wrote that these measures would not accurately reflect hospitals’ performance on cost. Since the payment measures would also include payments for care after hospital discharge, they would reflect the care of multiple providers, not just hospitals, according to the AHA. “Attributing the results solely to one part of the system (i.e., hospitals) is unfair,” the letter stated.

AHA said the measures would be appropriate only in a bundled payment context.

More Articles on Quality Measures:

CMS Begins Dry Run of Heart Attack Hospital Payment Measure
Pediatric Readmissions Aren’t a Useful Quality Measure, Study Suggests
Study: Complication Rates Do Not Fully Explain Readmission Rate Variance

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.